Article Information
History
- July 19, 2024.
Article Versions
- Version 1 (July 14, 2024 - 20:55).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Shruti Chopra1,*,
- Lennart M. Roesner1,2,
- Katinka Döhner1,
- Jana Zeitvogel1,
- Stephan Traidl1,
- Elke Rodriguez3,4,
- Inken Harder3,
- Wolfgang Lieb5,
- Stephan Weidinger3,
- Thomas F. Schulz2,6,
- Beate Sodeik2,6 and
- Thomas Werfel1,2
- 1Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany
- 2Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany
- 3Department of Dermatology, Venereology, and Allergology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
- 4Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany
- 5Institute of Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
- 6Institute of Virology, Hannover Medical School, Hannover, Germany
- ↵*Corresponding author: Shruti Chopra, M.Sc., Department of Dermatology and Allergy Hannover Medical School, Carl-Neuberg-Str. 1, D-30623 Hannover, Germany Phone: ++49 - 511 - 532 5092, Email: chopra.shruti{at}mh-hannover.de
Posted July 19, 2024.
Identification and characterization of collagen XXIII alpha 1 as a novel risk factor for eczema herpeticum
